Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP454878.RAUvQ6mvN2MGwvmxuhJY2IlkdNz0YhBmBMjMV1zDdBd_E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP454878.RAUvQ6mvN2MGwvmxuhJY2IlkdNz0YhBmBMjMV1zDdBd_E130_assertion type Assertion NP454878.RAUvQ6mvN2MGwvmxuhJY2IlkdNz0YhBmBMjMV1zDdBd_E130_head.
- NP454878.RAUvQ6mvN2MGwvmxuhJY2IlkdNz0YhBmBMjMV1zDdBd_E130_assertion description "[The present study has shown for the first time that phosphorylation of ER-alpha Ser167, but not Ser118, and expression of PRA and PRB, as well as ER-alpha and PR in primary breast tumors are predictive of response to endocrine therapy, whereas expression of ER-beta1 and ER-betacx/beta2 did not affect response to the therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454878.RAUvQ6mvN2MGwvmxuhJY2IlkdNz0YhBmBMjMV1zDdBd_E130_provenance.
- NP454878.RAUvQ6mvN2MGwvmxuhJY2IlkdNz0YhBmBMjMV1zDdBd_E130_assertion evidence source_evidence_literature NP454878.RAUvQ6mvN2MGwvmxuhJY2IlkdNz0YhBmBMjMV1zDdBd_E130_provenance.
- NP454878.RAUvQ6mvN2MGwvmxuhJY2IlkdNz0YhBmBMjMV1zDdBd_E130_assertion SIO_000772 16168121 NP454878.RAUvQ6mvN2MGwvmxuhJY2IlkdNz0YhBmBMjMV1zDdBd_E130_provenance.
- NP454878.RAUvQ6mvN2MGwvmxuhJY2IlkdNz0YhBmBMjMV1zDdBd_E130_assertion wasDerivedFrom befree-20140225 NP454878.RAUvQ6mvN2MGwvmxuhJY2IlkdNz0YhBmBMjMV1zDdBd_E130_provenance.
- NP454878.RAUvQ6mvN2MGwvmxuhJY2IlkdNz0YhBmBMjMV1zDdBd_E130_assertion wasGeneratedBy ECO_0000203 NP454878.RAUvQ6mvN2MGwvmxuhJY2IlkdNz0YhBmBMjMV1zDdBd_E130_provenance.